Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

For Mental Health Awareness Week 2019, the Oxford Science Blog explores how the University of Oxford has been researching the potential of online psychological treatments to support better mental health care.

The effects of the internet revolution over the past decade alone has been astounding. From the palm of our hand, the top of our desks and in our pockets, we have drastically altered the way we conduct our everyday lives and enhanced our capabilities.

The scale of internet use alone is evidence enough of its effects. According to the Office for National Statistics, 90% of adults in the UK reported being regular internet users and virtually all adults aged 16 to 34 reported being recent internet users (99% in 2018 compared to 44% of adults aged over 75).

Internet driven technologies have enhanced most aspects of our everyday existence, but what’s the potential for harnessing this capability for better health and care? We are seeing both national and local policies that are emphasising the need for embracing a spectrum of internet driven technologies to support professionals and patients alike.

But what about mental health? This Mental Health Awareness Week, the scale of the mental health challenge is serving as an urgent reminder as to why we should be embracing innovation in tackling it.

Read more (Oxford Science Blog, University of Oxford website)

Similar stories

Singula Bio, a new Oxford spin-out company - Cancer need not be fatal

General Innovation Research

Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.

Major rise in public support for COVID vaccine – Oxford study

Coronavirus COVID-19 General Research

More than three quarters of people in the UK now say they are ’very likely’ to have the vaccine – up from 50% among the same group of survey respondents five months ago –according to a two-wave Oxford University survey published today.

Coronavirus vaccination linked to substantial reduction in hospitalisation, real-world data suggests

Coronavirus COVID-19 General Research

The first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.

World’s largest clinical trial for COVID-19 treatments expands internationally

Clinical Trials Coronavirus COVID-19 General

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) Trial, the world’s largest clinical trial for COVID-19 treatments, has now expanded internationally with Indonesia and Nepal among the first countries to join. The first patients have been recruited to RECOVERY International.

Reprogramming tumour cells using an antimalarial drug

General Research

Results from the ATOM clinical trial at the University of Oxford have shown that the anti-malarial drug Atovaquone can reduce very low oxygen tumour environments. This has the potential to make cancers behave less aggressively and to improve the impact of everyday cancer treatments.